Wednesday, 08 April 2020

China News

  • Pharma companies set eyes on China

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with 40 deals and India and South...Read more

  • Alnylam and Ascletis collaborate to develop RNAi liver cancer therapeutic

    China |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jul, 2012

    Singapore: Alnylam Pharmaceuticals and Ascletis Pharmaceuticals have formed a strategic collaboration for the development of ALN-VSP, a first-in-class, systemically delivered RNAi therapeut...Read more

  • Calgary Scientific expands into China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2012

    Singapore: Calgary Scientific, a company known for creating transformative technology, is continuing to revolutionize global healthcare by expanding into Asia. Calgary Scientific hired Mr R...Read more

  • WuXi, OMT join hands to develop OmniRat antibodies

    China |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: WuXi PharmaTech (Cayman), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the US, and Open Monoclonal Technol...Read more

  • Korean, Chinese firms sign depression drug deal

    China |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

    Singapore: South Korean-based SK Biopharmaceuticals entered into a collaboration agreement with PKU International HealthCare, China, and Shanghai Medicilon, China, for its novel new small m...Read more

  • Del Mar, Guangxi Wuzhou join hands for cancer drug

    China |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

    Singapore: Del Mar Pharmaceuticals announced a strategic collaboration with Guangxi Wuzhou Pharmaceutical, a subsidiary of publicly traded Guangxi Wuzhou Zhongheng Group  for the developm...Read more

  • Pusey is new president, GM of WuXiPRA China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: China-based WuXiPRA, a contract research organization (CRO), has appointed Mr James Pusey, as president and general manager. Dr Pusey has more than 25 years of experience in medi...Read more

  • What the future holds for the APAC CRO market?

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • joimax goes BRIC and beyond

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Right on time with the soon expected registrations of the joimax products in Brazil - one of the most emerging BRIC economies - the German-based company showed a very successful...Read more

  • Eli Lilly, Strides expand in emerging markets

    China |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Bangalore: Eli Lilly and Company and Strides Arcolab have entered into a collaboration to expand delivery of cancer medicines in the emerging markets. As a part of this arrangement, Lilly ...Read more

  • China will overtake Japan in R&D spending: Report

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2013

    Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, investing billions of dollars and setting up innovation centers in a bid ...Read more

  • Hongquan Liu is new CEO of Simcere

    China |  News | By BioSpectrum Bureau  | 0 Comment | 14 Sep, 2012

    Singapore: Simcere Pharmaceutical, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, appoin...Read more

  • BMS, Simcere to develop, sell arthritis drug in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2013

    Singapore: Bristol-Myers Squibb (BMS) and China's Simcere Pharmaceutical have expanded their strategic relationship formed in 2010. The companies have agreed to collaborate in China on the...Read more

  • Perceptive opens customer care office in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2012

    Singapore: Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International, has opened a customer care office in Shanghai to service biopharmaceuti...Read more

  • Waters receives CFDA nod for new device

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2014

    Singapore: In a latest statement, Waters Corporation announced that the Chinese Food and Drug Administration (CFDA) has provided its approval for the registration of its new device. Waters'...Read more

  • Scientists confirm that bats are source of SARS

    China |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: A group of international scientists have isolated a close relative of the Severe Acute Respiratory Syndrome coronovirus (SARS-CoV) from horseshoe bats in China, confirming them a...Read more

  • Ambrx partners with WuXi to advance breast cancer treatement

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: In an effort to advance its breast cancer treatment, Ambrx has now partnered with WuXi PharmaTech and a Chinese drugmaker. As per the deal, Ambrx and Zhejiang Medicine will co-d...Read more

  • Thermo Fisher opens new facility in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Thermo Fisher Scientific, the world leader in serving science, announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consum...Read more